Immunopathogenesis of human immunodeficiency virus infection
- PMID: 8104513
Immunopathogenesis of human immunodeficiency virus infection
Abstract
Infection with human immunodeficiency virus (HIV) causes AIDS. As a consequence of the interaction of gp120 envelope with the CD4 receptor molecule expressed by a subset of T lymphocytes and by mononuclear phagocytes (MPs), a second envelope protein (gp41) mediates fusion of the virion membrane with the target membrane. In these events the role of adhesion molecules such as LFA-1 has recently been highlighted. Following viral entry, reverse transcription of the virion-associated RNA and integration of proviral DNA into the host genome are crucial steps in HIV infection, which can lead to expression of high levels of new HIV or to silent infection for indefinite periods, a condition defined as viral latency. Several factors in addition to endogenous viral regulatory proteins have been reported as capable of modulating the state of viral latency and expression in vitro, including the cytokine network that normally modulates immune homeostasis as well as the immune response to inflammatory stimuli. Finally, recent studies have underscored the observation that the CD4+ T lymphocytes are the major reservoir of HIV in the peripheral blood compartment and in the lymphoid tissues, which are characterized by a greater viral burden, whereas in nonlymphoid organs such as the brain and the lung, local infection is predominantly sustained by MPs.
Similar articles
-
Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.J Biol Regul Homeost Agents. 1996 Oct-Dec;10(4):83-91. J Biol Regul Homeost Agents. 1996. PMID: 9604776 Review.
-
Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?AIDS Rev. 2006 Jan-Mar;8(1):3-8. AIDS Rev. 2006. PMID: 16736946 Review.
-
Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.J Immunol. 1996 May 15;156(10):3994-4004. J Immunol. 1996. PMID: 8621941
-
Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.J Virol. 2007 Sep;81(18):9693-706. doi: 10.1128/JVI.00492-07. Epub 2007 Jul 3. J Virol. 2007. PMID: 17609262 Free PMC article. Clinical Trial.
-
Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization.Virology. 2000 Mar 15;268(2):493-503. doi: 10.1006/viro.2000.0190. Virology. 2000. PMID: 10704357
Cited by
-
Human Immunodeficiency Virus Type-1 (HIV-1) Transcriptional Regulation, Latency and Therapy in the Central Nervous System.Vaccines (Basel). 2021 Nov 3;9(11):1272. doi: 10.3390/vaccines9111272. Vaccines (Basel). 2021. PMID: 34835203 Free PMC article. Review.
-
The dual role of dendritic cells in the immune response to human immunodeficiency virus type 1 infection.J Gen Virol. 2008 Sep;89(Pt 9):2228-2239. doi: 10.1099/vir.0.83600-0. J Gen Virol. 2008. PMID: 18753232 Free PMC article.
-
CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts.J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):72-9. doi: 10.1097/QAI.0b013e318225ba62. J Acquir Immune Defic Syndr. 2011. PMID: 21654498 Free PMC article.
-
Insights into the HIV Latency and the Role of Cytokines.Pathogens. 2019 Sep 4;8(3):137. doi: 10.3390/pathogens8030137. Pathogens. 2019. PMID: 31487807 Free PMC article. Review.
-
Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy.J Acquir Immune Defic Syndr. 2014 May 1;66(1):55-64. doi: 10.1097/QAI.0000000000000125. J Acquir Immune Defic Syndr. 2014. PMID: 24463783 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials